Ethyl cyanohydroxyiminoacetate Ethyl cyanohydroxyiminoacetate Ethyl cyanohydroxyiminoacetate (oxyma) is the oxime of ethyl cyanoacetate and finds use as an additive for carbodiimides, such as dicyclohexylcarbodiimide (DCC) in peptide synthesis. It acts as a neutralizing reagent for the basicity or nucleophilicity of the DCC due to its pronounced acidity (pKa 4.60) and suppresses base catalyzed side reactions, in particular racemization. Ethyl cyanohydroxyiminoacetate is obtained in the reaction of ethyl cyanoacetate and nitrous acid (from sodium nitrite and acetic acid) in 87% yield. Because of the rapid hydrolysis of the ester, the reaction should be carried out at pH 4.5, in buffered phosphoric acid the
Sodium ethyl xanthate dose for (male albino mice, oral, 10% solution at pH~11) is 730 mg/kg of body weight, with most deaths occurring in the first day. The most affected organs were the central nervous system, liver and spleen. Since 1993, sodium ethyl xanthate is classified as a Priority Existing Chemical in Australia, meaning that its manufacture, handling, storage, use or disposal may result in adverse health or environment effects. This decision was justified by the widespread use of the chemical in industry and its decomposition to the toxic and flammable carbon disulfide gas. From two examples of sodium ethyl xanthate spillage in